annual current assets:
$695.47M+$279.00M(+66.99%)Summary
- As of today (June 2, 2025), ARWR annual total current assets is $695.47 million, with the most recent change of +$279.00 million (+66.99%) on September 30, 2024.
- During the last 3 years, ARWR annual current assets has risen by +$310.87 million (+80.83%).
- ARWR annual current assets is now at all-time high.
Performance
ARWR Current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current assets:
$1.14B+$564.68M(+98.97%)Summary
- As of today (June 2, 2025), ARWR quarterly total current assets is $1.14 billion, with the most recent change of +$564.68 million (+98.97%) on March 31, 2025.
- Over the past year, ARWR quarterly current assets has increased by +$593.57 million (+109.59%).
- ARWR quarterly current assets is now at all-time high.
Performance
ARWR quarterly current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ARWR Current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +67.0% | +109.6% |
| 3 y3 years | +80.8% | +171.8% |
| 5 y5 years | +162.2% | +261.0% |
ARWR Current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.8% | at high | +377.2% |
| 5 y | 5-year | at high | +162.2% | at high | +377.2% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ARWR Current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.14B(+99.0%) |
| Dec 2024 | - | $570.54M(-18.0%) |
| Sep 2024 | $444.33M(+27.3%) | $695.47M(+54.5%) |
| Jun 2024 | - | $450.06M(-16.9%) |
| Mar 2024 | - | $541.65M(+127.7%) |
| Dec 2023 | - | $237.90M(-42.9%) |
| Sep 2023 | $349.08M(+21.8%) | $416.47M(-11.4%) |
| Jun 2023 | - | $470.17M(-18.2%) |
| Mar 2023 | - | $574.81M(-0.0%) |
| Dec 2022 | - | $575.00M(+41.9%) |
| Sep 2022 | $286.64M(-12.0%) | $405.30M(-6.3%) |
| Jun 2022 | - | $432.39M(+3.5%) |
| Mar 2022 | - | $417.63M(+23.5%) |
| Dec 2021 | - | $338.28M(-12.0%) |
| Sep 2021 | $325.55M(+62.7%) | $384.60M(-26.9%) |
| Jun 2021 | - | $525.96M(-10.4%) |
| Mar 2021 | - | $586.76M(+81.3%) |
| Dec 2020 | - | $323.72M(+0.4%) |
| Sep 2020 | $200.13M(+136.6%) | $322.37M(+2.3%) |
| Jun 2020 | - | $315.23M(+0.2%) |
| Mar 2020 | - | $314.47M(-38.0%) |
| Dec 2019 | - | $507.61M(+91.4%) |
| Sep 2019 | $84.60M(+157.6%) | $265.25M(+8.5%) |
| Jun 2019 | - | $244.54M(+4.1%) |
| Mar 2019 | - | $234.97M(-5.6%) |
| Dec 2018 | - | $248.95M(+216.1%) |
| Sep 2018 | $32.84M(-9.1%) | $78.77M(+27.3%) |
| Jun 2018 | - | $61.87M(-33.2%) |
| Mar 2018 | - | $92.66M(+74.5%) |
| Dec 2017 | - | $53.11M(-21.8%) |
| Sep 2017 | $36.12M(-4.1%) | $67.90M(-12.8%) |
| Jun 2017 | - | $77.90M(-13.1%) |
| Mar 2017 | - | $89.69M(-15.6%) |
| Dec 2016 | - | $106.23M(+17.4%) |
| Sep 2016 | $37.67M(+28.2%) | $90.50M(+82.5%) |
| Jun 2016 | - | $49.60M(-25.0%) |
| Mar 2016 | - | $66.14M(-19.6%) |
| Dec 2015 | - | $82.28M(-20.0%) |
| Sep 2015 | $29.40M(+4.9%) | $102.87M(-10.3%) |
| Jun 2015 | - | $114.69M(-4.5%) |
| Mar 2015 | - | $120.15M(-9.1%) |
| Dec 2014 | - | $132.16M(-14.6%) |
| Sep 2014 | $28.02M(+230.1%) | $154.80M(-5.3%) |
| Jun 2014 | - | $163.42M(+0.9%) |
| Mar 2014 | - | $161.92M(+111.9%) |
| Dec 2013 | - | $76.41M(+164.9%) |
| Sep 2013 | $8.49M(-14.8%) | $28.84M(-16.2%) |
| Jun 2013 | - | $34.41M(+820.1%) |
| Mar 2013 | - | $3.74M(-38.3%) |
| Dec 2012 | - | $6.06M(-7.7%) |
| Sep 2012 | $9.96M | $6.57M(+11.3%) |
| Jun 2012 | - | $5.90M(-33.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $8.82M(-3.9%) |
| Dec 2011 | - | $9.17M(-7.0%) |
| Sep 2011 | $6.03M(+42.7%) | $9.86M(+39.9%) |
| Jun 2011 | - | $7.05M(-17.9%) |
| Mar 2011 | - | $8.58M(-22.3%) |
| Dec 2010 | - | $11.04M(+35.8%) |
| Sep 2010 | $4.22M(-19.1%) | $8.13M(-19.7%) |
| Jun 2010 | - | $10.13M(+238.6%) |
| Mar 2010 | - | $2.99M(-27.9%) |
| Dec 2009 | - | $4.15M(+67.0%) |
| Sep 2009 | $5.22M(-22.0%) | $2.48M(-9.8%) |
| Jun 2009 | - | $2.75M(-34.1%) |
| Mar 2009 | - | $4.18M(-53.7%) |
| Dec 2008 | - | $9.02M(-14.6%) |
| Sep 2008 | $6.69M(+47.2%) | $10.56M(-27.4%) |
| Jun 2008 | - | $14.54M(-29.2%) |
| Mar 2008 | - | $20.55M(-21.6%) |
| Dec 2007 | - | $26.21M(+3.6%) |
| Sep 2007 | $4.55M(-20.9%) | $25.31M(-21.2%) |
| Jun 2007 | - | $32.11M(+42.7%) |
| Mar 2007 | - | $22.49M(-21.9%) |
| Dec 2006 | - | $28.81M(+0.1%) |
| Sep 2006 | $5.75M(-7.7%) | $28.78M(-8.2%) |
| Jun 2006 | - | $31.34M(-13.2%) |
| Mar 2006 | - | $36.11M(+85.0%) |
| Dec 2005 | - | $19.52M(-14.4%) |
| Sep 2005 | $6.23M(+157.4%) | $22.81M(-11.1%) |
| Jun 2005 | - | $25.66M(+164.5%) |
| Mar 2005 | - | $9.70M(+32.7%) |
| Dec 2004 | - | $7.31M(-23.0%) |
| Sep 2004 | $2.42M(>+9900.0%) | $9.50M(-13.2%) |
| Jun 2004 | - | $10.94M(-4.9%) |
| Mar 2004 | - | $11.50M(+440.9%) |
| Dec 2003 | - | $2.13M(+40.4%) |
| Sep 2003 | $2000.00(-93.6%) | $1.51M(+7546.0%) |
| Jun 2003 | - | $19.80K(+30.3%) |
| Mar 2003 | - | $15.20K(-15.6%) |
| Dec 2002 | - | $18.00K(-43.9%) |
| Sep 2002 | $31.40K(+7750.0%) | $32.10K(-53.9%) |
| Jun 2002 | - | $69.70K(+44.9%) |
| Mar 2002 | - | $48.10K(-0.2%) |
| Dec 2001 | - | $48.20K(+5.0%) |
| Sep 2001 | $400.00(-99.2%) | $45.90K(-20.9%) |
| Jun 2001 | - | $58.00K(-0.5%) |
| Mar 2001 | - | $58.30K(+288.7%) |
| Dec 2000 | - | $15.00K(-6.8%) |
| Sep 2000 | $49.10K(-12.2%) | $16.10K(-0.6%) |
| Jun 2000 | - | $16.20K(-4.1%) |
| Mar 2000 | - | $16.90K(+6.3%) |
| Dec 1999 | - | $15.90K |
| Sep 1999 | $55.90K(-12.8%) | - |
| Sep 1998 | $64.10K(-12.9%) | - |
| Sep 1997 | $73.60K | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual current assets year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly current assets year-on-year change?
What is Arrowhead Pharmaceuticals annual total current assets?
The current annual current assets of ARWR is $695.47M
What is the all time high annual current assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total current assets is $695.47M
What is Arrowhead Pharmaceuticals annual current assets year-on-year change?
Over the past year, ARWR annual total current assets has changed by +$279.00M (+66.99%)
What is Arrowhead Pharmaceuticals quarterly total current assets?
The current quarterly current assets of ARWR is $1.14B
What is the all time high quarterly current assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total current assets is $1.14B
What is Arrowhead Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, ARWR quarterly total current assets has changed by +$593.57M (+109.59%)